IBC Members Page

IBC Members Page

Resources:	Reviewer Form v1 (Open format word document)
	Reviewer Form v2 (Fillable Field Document)
	Miami Review Policy and Exemptions
	NIH Guidelines Overview
	IBC Appointment Letter

New applications (5 Day All-Committee comments period)
These applications should be considered by all members. If after 5 days no member has requested a convened committee review, one or more members will be designated to be part of the review subcommittee.
Application Number	PI	Date Posted	Type: rDNA or BioHazard	Title	Type of review required*

* Committee members can call for a convened meeting to discuss any application regardless of NIH or local policy requirements, see Miami Review Policy ands Exemption link above.

Applications under review (post-5 day comment period)
Application Number	PI	Date Posted	Type: rDNA or BioHazard	Title	Type of review required*

Approved Protocols
Protocol Number	PI	Date Approved	Type: rDNA or BioHazard	Title
001	Kennedy	30-Apr-2016	rDNA	Methods development for human Pancreatic Cancer cell-line metabonomics studies: Growth media comparison and drying comparison
002	Kennedy	30-Apr-2016	rDNA	Engineering Oncolytic Adenoviruses for Pancreatic Cancer Therapy
003	Kennedy	30-Apr-2016	rDNA	Characterizing Biomarkers of Pancreatic Cancer in an Orthotopic Mouse Model
004	Zhu	30-Apr-2016	BioH	Mass spectrometry based metabolomics for the study of bacterial metabolites and their impact to human colorectal health
005	Ferguson	30-Apr-2016	BioH	Alternative routes of gut microbial methylamine metabolism that may limit trimethylamine N-oxide, a trigger for atherosclerosis (RG1).
007	Robinson	7-Apr-16	rDNA	Adenovirus use in tissue explants and cultured cells
008	Kennedy	22-Sep-16	rDNA	Assessment of Toxicity and Systemic Distribution of an Engineered Adenovirus Containing a HMGA1 Hyperbinding Site in C57BL/6 Mouse Model (PDF)
010	Wilson	17-Apr-17	rDNA	Use of 3rd generation lentiviral vectors for in vitro gene transfer (PDF)
011	Rao	5-Jul-17	Tech	FORESIGHT: Predicting & Preventing Emergent Epidemics in Humans & Livestock
012	Wilson	20-Dec-2017	Bio-Hazard (non-human)	Regulation of Immune Responses to MCMV by SLAMF9
013	Actis	16-May-2019	BioHazard	Study of Acinetobacter baumannii virulence
014	Balish	5-Nov-2019	BioHazard BL2	Culture of Mycoplasmas from Human Urine Samples and Urethral Swabs
015	Schumacher	31-Oct-2019	rDNA - BL1	Endocardial development in zebrafish

Complete NIH Guidlines (PDF)